Cargando…
The Glycolytic Pathway as a Target for Novel Onco-Immunology Therapies in Pancreatic Cancer
Pancreatic ductal adenocarcinoma (PDA) is one of the most lethal forms of human cancer, characterized by unrestrained progression, invasiveness and treatment resistance. To date, there are limited curative options, with surgical resection as the only effective strategy, hence the urgent need to disc...
Autores principales: | Curcio, Claudia, Brugiapaglia, Silvia, Bulfamante, Sara, Follia, Laura, Cappello, Paola, Novelli, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998946/ https://www.ncbi.nlm.nih.gov/pubmed/33804240 http://dx.doi.org/10.3390/molecules26061642 |
Ejemplares similares
-
Next Generation Immunotherapy for Pancreatic Cancer: DNA Vaccination is Seeking New Combo Partners
por: Cappello, Paola, et al.
Publicado: (2018) -
In pancreatic cancer, chemotherapy increases antitumor responses to tumor-associated antigens and potentiates DNA vaccination
por: Mandili, Giorgia, et al.
Publicado: (2020) -
The dark side of immunotherapy: pancreatic cancer
por: Mucciolo, Gianluca, et al.
Publicado: (2020) -
A self antigen reopens the games in pancreatic cancer
por: Cappello, Paola, et al.
Publicado: (2013) -
CD155, an onco‐immunologic molecule in human tumors
por: Gao, Jian, et al.
Publicado: (2017)